Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Generic propoxyphene: need for clinical bioavailability evaluation.

K A DeSante, R G Stoll, D G Kaiser

    Journal of Pharmaceutical Sciences
    |December 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pharmacokinetics, safety, and tolerability of atomoxetine and effect of CYP2D6*10/*10 genotype in healthy Japanese men.

    Journal of clinical pharmacology·2011
    Same author

    Comparison of the in vitro and in vivo release of digoxin from four different soft gelatin capsule formulations.

    Journal of pharmacokinetics and biopharmaceutics·2010
    Same author

    Confidence interval criteria for assessment of dose proportionality.

    Pharmaceutical research·2001
    Same author

    Why rate of absorption inferences in single dose bioequivalence studies are often inappropriate.

    Pharmaceutical research·1998
    Same author

    Pressor response to tyramine after single 24-hour application of a selegiline transdermal system in healthy males.

    Journal of clinical pharmacology·1997
    Same author

    Toxicokinetic evaluation of a selegiline transdermal system in the dog.

    Biopharmaceutics & drug disposition·1997
    Same journal

    Green, renewable, or low-carbon? A framework for informed solvent selection in pharmaceutical sciences.

    Journal of pharmaceutical sciences·2026
    Same journal

    Theranostic potential of ramucirumab functionalized magnetoliposomes for targeted delivery of sorafenib and MRI.

    Journal of pharmaceutical sciences·2026
    Same journal

    Intranasal mucoadhesive chitosan microspheres of ranolazine: Formulation, design, and pharmacokinetic evaluation.

    Journal of pharmaceutical sciences·2026
    Same journal

    Evolving landscape of drug development for pediatric rare diseases-from successes to strategies for addressing unmet needs.

    Journal of pharmaceutical sciences·2026
    Same journal

    A mathematical framework for predicting tablet weight variability from blend particle size distribution and tooling geometry.

    Journal of pharmaceutical sciences·2026
    Same journal

    Recrystallization can stop nitrosamine formation in ranitidine hydrochloride.

    Journal of pharmaceutical sciences·2026
    See all related articles

    Two propoxyphene capsule formulations showed different bioavailability despite similar properties. This highlights potential bioavailability issues with water-soluble drugs and poor correlation between in vitro and in vivo drug performance.

    Area of Science:

    • Pharmacokinetics
    • Drug Formulation
    • Bioavailability Studies

    Background:

    • Investigational capsule formulations of propoxyphene were developed with similar physicochemical parameters.
    • Propoxyphene is a commonly prescribed analgesic, making formulation studies critical for therapeutic efficacy.

    Purpose of the Study:

    • To compare the in vivo bioavailability of two propoxyphene capsule formulations.
    • To discuss bioavailability challenges associated with water-soluble drugs.
    • To explore the correlation between in vitro and in vivo parameters for drug formulations.

    Main Methods:

    • Plasma drug concentration data from human subjects administered two different propoxyphene capsule formulations.
    • Analysis of pharmacokinetic parameters to determine bioavailability.

    Related Experiment Videos

  • Comparative assessment of in vitro and in vivo drug performance metrics.

    • Main Results:

    • Significant differences in in vivo bioavailability were observed between the two propoxyphene formulations.
    • The study identified potential bioavailability issues inherent in water-soluble drug formulations.
    • A lack of correlation between in vitro and in vivo parameters was noted for these equivalent drug formulations.

    Conclusions:

    • Physicochemical similarity does not guarantee equivalent in vivo bioavailability for propoxyphene capsules.
    • Water-solubility presents challenges for consistent drug bioavailability.
    • Predictive correlation between in vitro and in vivo drug performance requires further investigation for formulation development.